Navigation Links
Novexel's NXL104/ceftazidime Combination Commences Second Phase II Clinical Trial in Hospital Patients With Complicated Intra-Abdominal Infections (cIAIs)
Date:3/3/2009

About NXL104

NXL104 is a novel injectable non beta lactam, beta-lactamase inhibitor, which is being developed to address the increasing problem of microbial resistance to beta lactam antibiotics (penicillins, cephalosporins, carbopenems) mediated by beta-lactamase enzymes.

NXL104 is a significant advance, as it is able to inhibit a broader range of beta-lactamases than currently marketed inhibitors. Its spectrum includes class A (including ESBL and KPC) and class C enzymes. NXL104 in combination with ceftazidime will be targeting infections caused by Gram negative bacteria, including Enterobacteriaceae and Pseudomonas.

About Novexel

Novexel is a speciality pharmaceutical company focused on the discovery and development of novel antibiotics designed to overcome the significant global problem of microbial resistance. The ever increasing resistance to marketed antibiotics has led to a clear need for novel drugs that are active against multi-drug resistant bacteria. Novexel's products are targeting the global hospital antibiotic market, which was worth an estimated $15bn in 2007 according to information derived from the IMS Midas(R) database.

Novexel currently has two novel antibacterials in Phase II clinical development. These are the injectable beta-lactamase inhibitor, NXL104, which is being developed in combination with the cephalosporin antibiotic ceftazidime for serious Gram negative infections, and the oral streptogramin antibiotic, NXL103, for the treatment of Gram positive infections, with a focus on treatment in the hospital setting and intravenous (IV) to oral switch. Novexel has three further programmes in preclinical development, NXL105, a novel anti-Pseudomonal antibiotic, NXL201, a novel echinocandin antifungal agent, and NXL104 in combination with ceftaroline. This latter product is being developed by our partner, Forest Laboratories, solely for North
'/>"/>

SOURCE Novexel
Copyright©2009 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Novexels NXL104/ceftazidime Combination Commences Phase II Clinical Trial in Hospital Patients With Complicated Urinary Tract Infections
2. CuraGen and TopoTarget Initiate Phase I/II Clinical Trial of Belinostat (PXD101) Combination Therapy for Acute Myeloid Leukemia
3. Abbott and AstraZeneca Announce Selection of Next-Generation Fenofibrate ABT-335 and CRESTOR(R) Fixed-Dose Combination
4. Study Shows Combination Therapy Incorporating AVODART(R) and Tamsulosin Provides Continuous Symptom Improvement Over 2 Years
5. Xeloda XeNA Study Analyses of Xeloda, Docetaxel and Herceptin Combination Therapy for Metastatic Breast Cancer Featured at Major New Breast Cancer Symposium
6. Xeloda(R) XeNA Study Analyses of Xeloda, Docetaxel and Herceptin Combination Therapy for Metastatic Breast Cancer Featured at Major New Breast Cancer Symposium
7. Vion Pharmaceuticals Announces Initiation of a Phase I/II Trial of Cloretazine(R) (VNP40101M) in Combination with Temodar(R) in Adult Brain Tumors
8. New Phase 3 Study in Treatment-Naive Adults with HIV Evaluates Efficacy and Safety of Once-Daily PREZISTA(TM)/ritonavir vs. KALETRA(R) as Part of HIV Combination Therapy
9. New Data Show Ceftobiprole as Effective as Combination Therapy in Treating Patients With Complicated Skin Infections, Including MRSA
10. European Unions CHMP Issues Positive Opinion on PEGINTRON(TM) Combination Therapy for Retreating Hepatitis C Patients Who Failed Previous Therapy
11. Pharmasset Commences Dosing in 28-Day Combination Study of R7128 with Pegasys(R) plus Copegus(R) for Hepatitis C
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/20/2013)... and WESTMINSTER, Colo. , June 20, 2013 ... US-based Surefire Medical today announced a sales and ... and specialty catheters for the interventional radiology and oncology markets. ... Surefire Medical range of products in the company,s rapidly growing ... Australia . Sirtex reported a 30 per ...
(Date:6/19/2013)... June 19, 2013 Pharmacyclics, Inc. (the "Company") ... The New England Journal of Medicine ( NEJM ... the investigational oral Bruton,s tyrosine kinase (BTK) inhibitor ibrutinib ... These data suggested ibrutinib may be effective and generally ... Results of a separate study examining the safety and ...
(Date:6/19/2013)... YORK , June 19, 2013 /PRNewswire-iReach/ -- ... pioneer of modern hair transplant procedures and founder ... was included in the ,Best Doctors, issue of ... (Photo:  http://photos.prnewswire.com/prnh/20130619/CG34629 ) ... Best Doctors issue, and his reputation as world-renowned ...
Breaking Medicine Technology:Sirtex To Distribute Surefire Medical's Innovative Infusion System in Australia and Asia Pacific Markets 2Ibrutinib Phase 2 Study Results in Patients with Mantle Cell Lymphoma Published in The New England Journal of Medicine 2Ibrutinib Phase 2 Study Results in Patients with Mantle Cell Lymphoma Published in The New England Journal of Medicine 3Ibrutinib Phase 2 Study Results in Patients with Mantle Cell Lymphoma Published in The New England Journal of Medicine 4Ibrutinib Phase 2 Study Results in Patients with Mantle Cell Lymphoma Published in The New England Journal of Medicine 5Ibrutinib Phase 2 Study Results in Patients with Mantle Cell Lymphoma Published in The New England Journal of Medicine 6Dr. Robert Bernstein in NY Magazine's 'Best Doctors' Issue for 14th Consecutive Year 2Dr. Robert Bernstein in NY Magazine's 'Best Doctors' Issue for 14th Consecutive Year 3
(Date:6/20/2013)... 20, 2013 Anant Goel, CEO at ... to empower children and adults with skills of the 21st ... that form the foundation for success in the new millennium. ... having access to technology does not automatically make us the ... for work, businesses, and life." , The ...
(Date:6/20/2013)... 20, 2013 As a key researcher ... Navneet Tyagi has remained closely linked to neurodegenerative ... of scientific research that Tyagi has participated in, he ... onset of these severe and mysterious neurological conditions. It ... researchers will be able to understand about the nature ...
(Date:6/20/2013)... Washington, DC (PRWEB) June 20, 2013 ... exchanges, the executive director of the Maryland Health Benefit ... Hub — “something that many in the industry consider,” ... post on AISHealth.com, “as mythical as unicorns and ... actually connected to the Federal Data Services Hub live,” ...
(Date:6/20/2013)... Mobile, a leading manufacturer and distributor of wholesale-direct-to-consumer ... of 16GB version of the Mini Studio Android tablet. ... tablet that is a direct competitor to the iPad ... it will be launched at promotional price at $121 ... Mini STUDIO is part of the Handgiftbox.com “STUDIO Series,” ...
(Date:6/20/2013)... 2013 Emotional abuse expert and author, ... and confronting tactics used by emotional abusers. In ... and not being spoken to for days, being blamed ... experienced these behaviors and more in her marriage to ... marriage for 13 years because she did not realize ...
Breaking Medicine News(10 mins):Health News:RKNet Studio Launched Online Website for Fun Games, Brain Training and Cognitive Skills Development 2Health News:RKNet Studio Launched Online Website for Fun Games, Brain Training and Cognitive Skills Development 3Health News:Navneet Tyagi Supports Continued Efforts for Alzheimer Detection Procedures 2Health News:Navneet Tyagi Supports Continued Efforts for Alzheimer Detection Procedures 3Health News:Federal Data Services Hub Does Exist, AISHealth.com Blog Post Reports 2Health News:Android Tablet PC Mini Studio with Android 4.1 with 16GB is Here at $121 Only at Handgiftbox.com 2Health News:Lisa Kroulik Empowers Women to Recognize Emotional Abuse in Intimate Relationships 2
... future of nanotechnology without talking about or with Mike ... National Nanotechnology Initiative (NNI)Americas $8 billion federal investment in ... and industry. , Nanotechnology refers to the emerging ... usually at the 1-100 nanometers scale. The head of ...
... the years, lead is not intentionally added to cosmetics.,Lead ... in the,environment. Consumers are exposed daily to lead when ... amount of lead a woman would be exposed to,when ... she would get from,eating, breathing, and drinking water that ...
... Organizations to Leverage Network Connections to Facilitate International ... ... Internet2 today announced a new,Memorandum of Understanding (MOU) with Rede ... networking organization of,Brazil, to facilitate international telehealth and telemedicine,collaborations. The ...
... Transfer to Healthcare Marketplace -, ATLANTA, Oct. ... community management (BCM) solutions, today announced it,is sponsoring ... Electronic Data Interchange (WEDI) Conference on Health Savings,Accounts ... BizManager,suite and Secure Link solution. The conference is ...
... through 20, WASHINGTON, Oct. 11 U.S. ... start of the second annual Drug-Free,Work Week, which ... October 20. A,collaborative effort of the department and ... of being drug-free to,keeping workplaces safe., "Drug-free ...
... of U.S. adults feel comfortable discussing it , , THURSDAY, Oct. ... politics and religion, many Americans are reluctant to discuss managing ... new survey of more than 1,000 adults. , The survey, ... they knew someone with a chronic illness, but only 34 ...
Cached Medicine News:Health News:The nanotech future: a conversation with Mihail Roco 2Health News:Internet2 and Rede Nacional de Ensino e Pesquisa Form Health Sciences Partnership 2Health News:Internet2 and Rede Nacional de Ensino e Pesquisa Form Health Sciences Partnership 3Health News:Inovis Sponsors ASC X12 Conference, Exhibits BizManager and Secure Link 2Health News:U.S. Secretary of Labor launches Drug-Free Work Week 2Health News:Chronic Illness Often a Taboo Subject: Survey 2Health News:Chronic Illness Often a Taboo Subject: Survey 3
... is a non-invasive massage machine for ... the circulatory system. Extraordinary results are ... action, which combines vertical and parallel ... percussion, gyratory massage, deep tissue mobilization, ...
The Ritter 204 Manual Exam Table. Featuring the latest in design, comfort and functionality in a manual exam table, it truly offers efficient patient care....
... 622 and 623 High-Low Examination Tables deliver the ... you. Many different types of patients can ... how to get on the exam table. Being ... ,can increase a patients comfort during the exam, ...
... MegaPeel microdermabrasion systems offer many features that ... save you time and money. Because our ... easy to use and maintain, you spend ... your microdermabrasion equipment. MegaPeel microdermabrasion systems are ...
Medicine Products: